AAIC 2026 Study Shows Blood Test Predicts Alzheimer’s Risk
LONDON, United Kingdom, July 15, 2026 New research presented at the Alzheimer’s Association International Conference (AAIC) 2026 has revealed...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LONDON, United Kingdom, July 15, 2026 New research presented at the Alzheimer’s Association International Conference (AAIC) 2026 has revealed...
NAIROBI, Kenya / KAMPALA, Uganda, June 19, 2026 African health leaders, government officials, clinicians, patient advocates, and international partners...
New York, USA – April 22, 2026 Utepreva announced the launch of its FDA 510(k)-cleared Endometrial Sampler, an innovative...
WASHINGTON, D.C., February 3, 2026 — As American Heart Month begins, the Alliance for Aging Research is leading a...
FAIRFAX, Va., January 22, 2026 — Re:Cognition Health announced that Medicare coverage is now available for FDA-approved amyloid-targeting therapies...
London, January 19, 2026 — Scientists from a major international collaboration led by LifeArc and the Global Alzheimer’s Platform...
